Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

66.00CHF
15 Dec 2017
Change (% chg)

CHF-0.40 (-0.60%)
Prev Close
CHF66.40
Open
CHF66.25
Day's High
CHF66.30
Day's Low
CHF65.70
Volume
85,986
Avg. Vol
107,491
52-wk High
CHF68.25
52-wk Low
CHF52.05

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.16
Market Cap(Mil.): CHF3,731.19
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.08

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-BB Biotech Q3 net profit down at CHF 365 million

* PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER

20 Oct 2017

BRIEF-BB Biotech reports 5.1 pct passive stake in Intra-Cellular Therapies

* BB Biotech AG reports 5.1 percent passive stake in Intra-Cellular Therapies Inc as of August 18, 2017 - SEC filing‍​ Source text: (http://bit.ly/2xcLrz4) Further company coverage:

23 Aug 2017

BRIEF-BB Biotech H1 net result turns to profit of CHF 478 mln

* ‍CONSEQUENTLY, H1 2017 NET INCOME AMOUNTED TO CHF 478 MN, COMPARED TO A LOSS OF CHF 1 170 MN FOR H1 2016​

21 Jul 2017

Earnings vs. Estimates